NASDAQ InMed Patent Application & Acquisition



The Dales Report is once again joined by InMed Pharmaceuticals Inc. (Nasdaq: INM) CEO Eric Adams who discuss about the recent acquisition of BayMedica …

3 Comments

Leave a Reply

Your email address will not be published.


*